<DOC>
	<DOCNO>NCT02220998</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy , safety , tolerability treatment sofosbuvir/velpatasvir ( SOF/VEL ) fixed-dose combination ( FDC ) 12 week compare treatment sofosbuvir ( SOF ) plus ribavirin ( RBV ) 12 week participant chronic genotype 2 hepatitis C virus ( HCV ) infection .</brief_summary>
	<brief_title>Comparison Sofosbuvir/Velpatasvir Fixed Dose Combination 12 Weeks With Sofosbuvir Ribavirin 12 Weeks Adults With Chronic Genotype 2 HCV Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Willing able provide write informed consent HCV RNA ≥ 10^4 IU/mL HCV genotype 2 Chronic HCV infection ( ≥ 6 month ) Females childbearing potential must negative serum pregnancy test Males females childbearing potential engage heterosexual intercourse must agree use protocol specify method ( ) contraception Must generally good health , exception chronic HCV infection , determine investigator . Current prior history clinicallysignificant illness ( HCV may interfere treatment , assessment compliance protocol ; Screening electrocardiogram ( ECG ) clinically significant abnormality Laboratory result outside acceptable range Screening Pregnant nursing female male pregnant female partner Chronic liver disease nonHCV etiology ( e.g. , hemochromatosis , Wilson 's disease , alfa1 antitrypsin deficiency , cholangitis ) Infection hepatitis B virus ( HBV ) human immunodeficiency virus ( HIV )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>HCV</keyword>
	<keyword>cirrhosis</keyword>
	<keyword>Sofosbuvir</keyword>
	<keyword>Sovaldi</keyword>
	<keyword>SOF/VEL</keyword>
	<keyword>GS-5816</keyword>
	<keyword>GS-7977</keyword>
	<keyword>liver</keyword>
	<keyword>Treatment naive</keyword>
	<keyword>Treatment Experience</keyword>
	<keyword>genotype 2</keyword>
</DOC>